High Tech Pharm Co., Ltd.

KOSDAQ:A106190 Stock Report

Market Cap: ₩138.6b

High Tech Pharm Future Growth

Future criteria checks 0/6

We currently don't have sufficient analyst coverage to forecast growth and revenue for High Tech Pharm.

Key information

n/a

Earnings growth rate

n/a

EPS growth rate

Pharmaceuticals earnings growth34.2%
Revenue growth raten/a
Future return on equityn/a
Analyst coverage

None

Last updatedn/a

Recent future growth updates

No updates

Recent updates

There's Reason For Concern Over High Tech Pharm Co., Ltd.'s (KOSDAQ:106190) Massive 25% Price Jump

May 09
There's Reason For Concern Over High Tech Pharm Co., Ltd.'s (KOSDAQ:106190) Massive 25% Price Jump

Is High Tech Pharm (KOSDAQ:106190) A Risky Investment?

Apr 23
Is High Tech Pharm (KOSDAQ:106190) A Risky Investment?

We Think High Tech Pharm (KOSDAQ:106190) Has A Fair Chunk Of Debt

Feb 23
We Think High Tech Pharm (KOSDAQ:106190) Has A Fair Chunk Of Debt

Did High Tech Pharm's (KOSDAQ:106190) Share Price Deserve to Gain 91%?

Jan 19
Did High Tech Pharm's (KOSDAQ:106190) Share Price Deserve to Gain 91%?

What Is The Ownership Structure Like For High Tech Pharm Co., Ltd. (KOSDAQ:106190)?

Dec 15
What Is The Ownership Structure Like For High Tech Pharm Co., Ltd. (KOSDAQ:106190)?

In this section we usually present revenue and earnings growth projections based on the consensus estimates of professional analysts to help investors understand the company’s ability to generate profit. But as High Tech Pharm has not provided enough past data and has no analyst forecast, its future earnings cannot be reliably calculated by extrapolating past data or using analyst predictions.

This is quite a rare situation as 97% of companies covered by SimplyWall St do have past financial data.

Earnings and Revenue Growth Forecasts

KOSDAQ:A106190 - Analysts future estimates and past financials data (KRW Millions)
DateRevenueEarningsFree Cash FlowCash from OpAvg. No. Analysts
12/31/202376,7728,076-2,1832,909N/A
9/30/202379,1758,114434,862N/A
6/30/202394,1027,9313,2076,159N/A
3/31/2023102,1506,7992,5744,034N/A
12/31/2022102,9475,873-4,359-3,703N/A
9/30/202288,68852,5002,834N/A
6/30/202270,212-1,205-5,808-5,020N/A
3/31/202267,869-2,977-3,475-2,615N/A
12/31/202173,287-1,2256,0686,928N/A
9/30/202179,120-1,054-6,260-5,124N/A
6/30/202185,343-367-3,739-3,289N/A
3/31/202179,496-2,535-5,737-4,921N/A
12/31/202074,462-3,152-8,628-7,691N/A
9/30/202072,142-5,630-5,701-4,966N/A
6/30/202073,147-7,340-588131N/A
3/31/202067,977-4,743-2,416-1,292N/A
12/31/201963,068-4,2183272,484N/A
9/30/201961,495-917-5,540-3,199N/A
6/30/201954,3811,116-5,468509N/A
3/31/201960,0132,413-4,2313,574N/A
12/31/201866,3882,608-3,5835,379N/A
9/30/201869,8532,711-30410,853N/A
6/30/201870,4302,863-3519,507N/A
3/31/201867,5932,64013210,103N/A
12/31/201766,0502,100-5,8165,452N/A
9/30/201765,5344,866N/A3,572N/A
6/30/201758,8473,514N/A-95N/A
3/31/201754,0814,449N/A-366N/A
12/31/201654,8365,280N/A1,448N/A
9/30/201650,6603,024N/A3,178N/A
6/30/201653,3735,400N/A4,446N/A
3/31/201653,4526,263N/A7,419N/A
12/31/201548,0926,544N/A12,709N/A
9/30/201547,6048,613N/A13,701N/A
6/30/201545,8449,079N/A17,227N/A
3/31/201549,2647,038N/A13,997N/A
12/31/201456,8977,835N/A10,173N/A
9/30/201458,7406,651N/A14,917N/A
6/30/201464,7225,597N/A9,618N/A
3/31/201468,2489,260N/A9,152N/A
12/31/201365,18310,455N/A6,408N/A
9/30/201362,2468,818N/A6,478N/A
6/30/201356,6939,308N/A14,368N/A

Analyst Future Growth Forecasts

Earnings vs Savings Rate: Insufficient data to determine if A106190's forecast earnings growth is above the savings rate (2.5%).

Earnings vs Market: Insufficient data to determine if A106190's earnings are forecast to grow faster than the KR market

High Growth Earnings: Insufficient data to determine if A106190's earnings are expected to grow significantly over the next 3 years.

Revenue vs Market: Insufficient data to determine if A106190's revenue is forecast to grow faster than the KR market.

High Growth Revenue: Insufficient data to determine if A106190's revenue is forecast to grow faster than 20% per year.


Earnings per Share Growth Forecasts


Future Return on Equity

Future ROE: Insufficient data to determine if A106190's Return on Equity is forecast to be high in 3 years time


Discover growth companies

Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.